GGrantIndex
← Search

Rapid Diagnostic for Human Cytomegalovirus (HCMV) Serological Status

$1,500,000N44FY2019AINIH

Nanocomposix, Inc., San Diego CA

Investigators

Abstract

This proposal aims to develop a point-of-care diagnostic to detect the presence of antibodies against human cytomegalovirus (HCMV).

View original record on NIH RePORTER →